These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 15082225)
1. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Gruss M; Braun K Neurochem Int; 2004 Jul; 45(1):81-8. PubMed ID: 15082225 [TBL] [Abstract][Full Text] [Related]
2. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. Gruss M; Braun K Neural Plast; 2001; 8(4):285-98. PubMed ID: 12018775 [TBL] [Abstract][Full Text] [Related]
3. Sex- and region-specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice. Fan Y; Zhang J; Sun XL; Gao L; Zeng XN; Ding JH; Cao C; Niu L; Hu G J Neurosci Res; 2005 Nov; 82(4):458-64. PubMed ID: 16237719 [TBL] [Abstract][Full Text] [Related]
4. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Qin M; Kang J; Smith CB Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968 [TBL] [Abstract][Full Text] [Related]
5. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology. Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451 [TBL] [Abstract][Full Text] [Related]
6. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Li J; Pelletier MR; Perez Velazquez JL; Carlen PL Mol Cell Neurosci; 2002 Feb; 19(2):138-51. PubMed ID: 11860268 [TBL] [Abstract][Full Text] [Related]
7. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531 [TBL] [Abstract][Full Text] [Related]
8. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058 [TBL] [Abstract][Full Text] [Related]
9. Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. El Idrissi A; Ding XH; Scalia J; Trenkner E; Brown WT; Dobkin C Neurosci Lett; 2005 Apr; 377(3):141-6. PubMed ID: 15755515 [TBL] [Abstract][Full Text] [Related]
10. Fragile X syndrome, the Fragile X related proteins, and animal models. Hoogeveen AT; Willemsen R; Oostra BA Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450 [TBL] [Abstract][Full Text] [Related]
11. Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse. Tervonen T; Akerman K; Oostra BA; Castrén M Brain Res Mol Brain Res; 2005 Jan; 133(1):162-5. PubMed ID: 15661377 [TBL] [Abstract][Full Text] [Related]
12. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577 [TBL] [Abstract][Full Text] [Related]
13. Transgenic mouse model for the fragile X syndrome. Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056 [TBL] [Abstract][Full Text] [Related]
14. Long-term potentiation in the hippocampus of fragile X knockout mice. Godfraind JM; Reyniers E; De Boulle K; D'Hooge R; De Deyn PP; Bakker CE; Oostra BA; Kooy RF; Willems PJ Am J Med Genet; 1996 Aug; 64(2):246-51. PubMed ID: 8844057 [TBL] [Abstract][Full Text] [Related]
15. [Fragile X syndrome: a model of gene-brain-behaviour relationships]. Hagerman RJ; Hagerman PJ Rev Neurol; 2001 Oct; 33 Suppl 1():S51-7. PubMed ID: 12447820 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome. Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086 [TBL] [Abstract][Full Text] [Related]
18. The fragile X syndrome: from molecular genetics to neurobiology. Willemsen R; Oostra BA; Bassell GJ; Dictenberg J Ment Retard Dev Disabil Res Rev; 2004; 10(1):60-7. PubMed ID: 14994290 [TBL] [Abstract][Full Text] [Related]
19. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225 [TBL] [Abstract][Full Text] [Related]
20. Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice. Lauterborn JC Brain Res Mol Brain Res; 2004 Nov; 131(1-2):101-9. PubMed ID: 15530658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]